Turkish scientists have developed a new technology that performs a precise diagnosis of the mutated new SARS-CoV-2 variant, which takes 8 hours, in 40 minutes. With Turkish technology, the detection of whether the mutated SARS-CoV-2 is in a geography and the tracking of the propagation rate in the regions where it is detected will be accelerated and easier. The new technology developed by Bioeksen has been used by the Ministry of Health of the Republic of Turkey in field screenings. The technology, which is the first in the world, can be exported to countries affected by mutation.
Bioeksen has recently achieved to enter the emergency use list with the approval of the World Health Organization with the “Bio-Speedy® SARS-CoV-2 (2019-nCoV) qPCR Detection Kit, developed in cooperation with Bioeksen R&D Technologies and the Ministry of Health, announced the new technology.
The coronavirus mutation has been at the center of the world agenda lately. While scientific research in the UK has shown a rapid increase in the number of cases in the UK since November, officials warn that the UK National Health Service is in danger of being unable to cope with the number of patients. While the studies indicate that the reason for this increase is a new variant of the SARS-CoV-2 virus, it also shows that the rate of this variant, which is rarely encountered in mid-November, reached 1% of the positives in the geography where it is located in a short period of 60 month.
Countries affected by the mutation are not limited to the UK either. Scientific studies conducted in December show that the variant is also available in Denmark, Ireland, Israel, the Netherlands, Iceland, Switzerland, Germany, Italy, France, Sweden and most recently in America. Scientists predict that due to the variant's high speed of propagation, it could soon become the dominant SARS-CoV-2 all over the world.
Reducing the 8-hour diagnosis time to 40 minutes
While these developments are taking place in the world, Turkish scientists have announced that they have developed a new technology that performs the definitive diagnosis of the mutated new SARS-CoV-2 variant, which takes 8 hours, in 40 minutes. The technology developed by Bioeksen, which will detect whether the mutated SARS-CoV-2 is in a geography and accelerate the tracking of the spreading rate in the regions where it is detected, started to be used by the Ministry of Health of the Republic of Turkey in field screenings.
Bioeks the statement made by the R & D Technologies: "mutant variant of the future will be experienced rapid detection whether in circulation in Turkey is meant to increase early detection of abnormal cases. In addition, with the rapid tests to be carried out at the entry points to the country, the entry of this variant into our country will be prevented. Another issue that should be emphasized is that the current vaccines have not yet been tested for their effectiveness on the mutant variant. It was underlined that, thanks to the new technology developed, "mutant screening" can be completed in a short time and with low costs, which will take months and can be completed with very high costs with the "DNA sequencing" method that requires high cost and time to apply to a large number of samples.
New technology developed by Bioeksen started to be used in field scans.
Turkey in the first SARS-CoV-2 detection kit of the Ministry of Health of the Bioeks develops cooperation with the mutant variant that developed a technology associated with fast and accurate diagnosis that occurred on December 25 announced that the Turkish Society for Microbiology Congress. With the developed kit, a large number of samples can be analyzed in less than 40 minutes and the definitive diagnosis of the new variant can be made. The Ministry has started field scans using the newly developed technology.